HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jaconi, S. Articles by Siegenthaler, G. Search for Related Content PubMed Articles by Jaconi, S. Articles by Siegenthaler, G.

Analysis of normal and truncated holo- and apo-retinol-binding protein (RBP) in human serum: altered ratios in chronic renal failure

Jaconi S, Saurat J-H, Siegenthaler G. Analysis of normal and truncated holo- and apo-retinol-binding protein (RBP) in human serum: altered ratios in chronic renal failure. Eur J Endocrinol 1996;134:576–82. ISSN 0804–4643

Retinol, the precursor of the retinoic acid hormone, is transported in the serum by a specific carrier, the retinol-binding protein (RBP). Compared to serum of healthy controls, the serum of patients with chronic renal failure (CRF) contains markedly increased levels of the RBP form truncated at the C-terminal, des(¹⁸²Leu-¹⁸³Leu). (RBP₂). which suggests that RBP₂ is cleared by the kidney in healthy people but accumulates in serum of CRF patients (Jaconi S, et al. J Lipid Res 1995;36:1247–53). To understand better the mechanism of retinol transport, we have developed a new analytical strategy to analyze the various forms of RBP that circulate in the blood: RBP with and without retinol (holo- and apo-RBP, respectively), RBP bound or not to transthyretin (TTR) and to determine in which of these forms RBP₂ circulates. We confirm, but now by direct measurement, that holo-RBP and, to a larger extent, apo-RBP are increased in CRF serum compared to normal serum. We also show that almost all apo-RBP and about 50% of total holo-RBP, corresponding to RBP excess in CRF serum, circulate free and are not complexed to TTR, the remaining 50% being complexed to TTR. This observation suggests that the high levels of free holo-RBP, not bound to TTR, which correspond to the increase in total RBPs measured in CRF serum, may alter the tissue uptake of retinol and be responsible for the signs of hypervitaminosis A observed in these patients. Secondly, we found that the truncation resulting in RBP₂ does not alter its binding properties for retinol nor those of holo-RBP₂ for TTR. We observed that the high amounts of free holo-RBP₂ and holo-RBP in sera of CRF patients were low in normal serum, suggesting that these forms are cleared by the kidney in normal conditions. The possible role of free holo-RBPs is discussed in the context of retinol recycling.

Georges Siegenthaler, Clinique de Dermatologie, Hôpital Cantonal Universitaire, CH-1211 Geneve 14, Switzerland

This article has been cited by other articles:

				G. Zhao, Z. Li, K. Araki, K. Haruna, K. Yamaguchi, M. Araki, M. Takeya, Y. Ando, and K.-i. Yamamura Inconsistency between hepatic expression and serum concentration of transthyretin in mice humanized at the transthyretin locus Genes Cells, December 1, 2008; 13(12): 1257 - 1268. [Abstract] [Full Text] [PDF]

				M. Promintzer, M. Krebs, J. Todoric, A. Luger, M. G. Bischof, P. Nowotny, O. Wagner, H. Esterbauer, and C. Anderwald Insulin Resistance Is Unrelated to Circulating Retinol Binding Protein and Protein C Inhibitor J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4306 - 4312. [Abstract] [Full Text] [PDF]

				M. Ziegelmeier, A. Bachmann, J. Seeger, U. Lossner, J. Kratzsch, M. Bluher, M. Stumvoll, and M. Fasshauer Serum Levels of Adipokine Retinol-Binding Protein-4 in Relation to Renal Function Diabetes Care, October 1, 2007; 30(10): 2588 - 2592. [Abstract] [Full Text] [PDF]